Showing results (361-370 of 403) with videos related to
Sort By:
Pageof 41
The Journal of Antimicrobial Chemotherapy|April 1, 2021
2021 update to HIV-TRePS: a highly flexible and accurate system for the prediction of treatment response from incomplete baseline information in different healthcare settingsAndrew D Revell, Dechao Wang, Maria-Jesus Perez-Elias, et al.Plos Medicine|November 22, 2013
When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern AfricaMichael Schomaker, Matthias Egger, James Ndirangu, et al.Journal of the International AIDS Society|July 9, 2020
Trends in CD4 and viral load testing 2005 to 2018: multi-cohort study of people living with HIV in Southern AfricaElizabeth Zaniewski, Cam H Dao Ostinelli, Frédérique Chammartin, et al.Antimicrobial Agents and Chemotherapy|September 10, 2015
Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal MeningitisTihana Bicanic, Christian Bottomley, Angela Loyse, et al.Plos Pathogens|February 1, 2021
Capture and visualization of live Mycobacterium tuberculosis bacilli from tuberculosis patient bioaerosolsRyan Dinkele, Sophia Gessner, Andrea McKerry, et al.Plos Medicine|January 27, 2011
Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan AfricaMatthias Egger, Ben D Spycher, John Sidle, et al.Cell Reports|September 25, 2025
Radiofrequency regulates the BET-mediated pathways in radial glia differentiation in human cortical developmentBilal Cakir, Yoshiaki Tanaka, Mu Seog Choe, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2020
Cost-effectiveness of a Novel Lipoarabinomannan Test for Tuberculosis in Patients With Human Immunodeficiency VirusKrishna P Reddy, Claudia M Denkinger, Tobias Broger, et al.The Lancet. HIV|January 9, 2017
Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trialJemma O'Connor, Michael J Vjecha, Andrew N Phillips, et al.BMC Infectious Diseases|June 30, 2012
Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settingsAlexandra Calmy, Eric Balestre, Fabrice Bonnet, et al.Pageof 41